KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Current Assets (2016 - 2025)

Emergent BioSolutions' Current Assets history spans 16 years, with the latest figure at $662.5 million for Q4 2025.

  • For Q4 2025, Current Assets rose 10.66% year-over-year to $662.5 million; the TTM value through Dec 2025 reached $662.5 million, up 10.66%, while the annual FY2025 figure was $662.5 million, 10.66% up from the prior year.
  • Current Assets reached $662.5 million in Q4 2025 per EBS's latest filing, down from $786.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.3 billion in Q4 2021 to a low of $598.7 million in Q4 2024.
  • Average Current Assets over 5 years is $904.5 million, with a median of $782.3 million recorded in 2023.
  • Peak YoY movement for Current Assets: surged 88.49% in 2021, then plummeted 44.13% in 2024.
  • A 5-year view of Current Assets shows it stood at $1.3 billion in 2021, then decreased by 4.69% to $1.2 billion in 2022, then tumbled by 43.86% to $679.5 million in 2023, then decreased by 11.89% to $598.7 million in 2024, then rose by 10.66% to $662.5 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Current Assets are $662.5 million (Q4 2025), $786.9 million (Q3 2025), and $719.5 million (Q2 2025).